A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
NCT06610227
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
BIOLOGICAL:
SapRNA™-MICA/B Tumor Vaccine
Sponsor
NING LI